MedTrace Logo

Dosing Study of Cranberry Capsules for the Prevention of Bacteriuria in Nursing Home Residents

NCT01033383 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2013-08-15

Study results available
· View outcomes & findings →

Summary

This study will investigate whether there is a particular dose of cranberry capsules that is effective in preventing the occurrence of urinary tract infections in females at least 65 years of age or older who live in a nursing home and who have a history of urinary tract infections. The Yale research team will be enrolling 80 subjects in total over several nursing home locations within Connecticut.

Conditions

  • Bacteriuria

Interventions

DIETARY_SUPPLEMENT

Placebo

36 milligram (mg) placebo capsule taken before quiet hours of sleep (qhs).

DIETARY_SUPPLEMENT

Cranberry Capsule

36 milligram (mg) cranberry capsule, taken before quiet hours of sleep (qhs).

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • National Center for Research Resources (NCRR)

    collaborator NIH

  • Yale University

    lead OTHER

Principal Investigators

  • Manisha Juthani-Mehta, MD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2010-10-31
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01033383 on ClinicalTrials.gov